US orders 22.5 million doses of bird flu vaccine
As part of the US government's effort to stockpile
vaccine in case of a pandemic flu outbreak, the Department of Health and Human
Services (HHS) has ordered additional doses of GlaxoSmithKline's bird flu
Glaxo, the company supplying the vaccine, has said that the HHS Department
has placed an order for 22.5 million doses of its vaccine to prevent or reduce
the spread of the H5N1 flu strain. This follows another order made in November
2006 of 5 million doses.
The company also said that it has initiated Phase I/II clinical trials for
its pre-pandemic vaccine. The studies will test the vaccine alone and in
combination with one of Glaxo's adjuvant agents, which can boost the vaccine's
strength. Results are expected early 2008.
To comment, login here
Or register to be able to comment.